Martinez Valenzuela, LauraLino, LuisGomez Preciado, FranciscoFulladosa, XavierCruzado, Josep Ma.Torras Ambròs, JoanDraibe, Juliana2025-01-082025-01-082024-05-011460-2385https://hdl.handle.net/2445/217316Comunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024Immune checkpoint inhibitors (ICI) have transformed cancer treatment, but they may lead to immune- mediated acute interstitial nephritis (ICI-AIN), in 2-5% of patients. About 35-40% show full kidney function recovery three months post ICI-AIN. Limited evidence exists for long-term renal toxicity.2 p.application/pdfeng(c) Martinez Valenzuela, Laura et al., 2024ImmunoteràpiaMalalties del ronyóImmunotheraphyKidney diseasesinfo:eu-repo/semantics/conferenceObject2024-12-13info:eu-repo/semantics/openAccess